raloxifene

raloxifene

 英

  • 網絡雷洛昔芬;雷洛西芬;那洛西芬

例句

However, researchers showed that raloxifene in combination with systemic oestrogen results in an increase in hyperplasia, she said.

然而研究人員指出雷洛全身雌激素效應導致異常增生增加

The Multiple Outcomes of Raloxifene Evaluation study was the pivotal treatment trial for raloxifene.

結局雷洛評價研究關鍵審判雷洛治療

Raloxifene, a selective estrogen receptor modulator, is approved for the prevention and treatment of postmenopausal osteoporosis.

雷洛選擇性激素受體調節批準用于預防治療絕經后骨質疏松癥

Raloxifene is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

雷洛用來預防治療絕經后婦女骨質疏松

Interestingly, hyperplastic polyps occurred only in the raloxifene and placebo treatment groups.

有趣增生息肉僅見雷洛安慰劑治療

Conclusion: Alendronate is more reasonable and economical than raloxifene in treating postmenopausal osteoporosis.

結論應用阿侖磷酸鈉治療絕經后婦女骨質疏松癥更為合理經濟

Selective estrogen-receptor modulators (eg, raloxifene) may reduce risk of developing breast cancer.

選擇性雌激素受體調節減少危險

C. Raloxifene (Evista) is a selective estrogen receptor modulator. It is available for prevention and treatment of osteoporosis.

雷洛Evista一種選擇性雌激素受體調節劑可以用來防治骨質疏松癥

Despite this risk, tamoxifen and another drug in this class, raloxifene, remain an extensively used and popular treatment.

雖然存在這些副作用一種同類藥物-雷洛西芬已經廣泛用于乳腺癌治療

Roughly half were given daily raloxifene pills and the others, dummy pills. Neither they nor their doctors knew who was taking what.

大約一半服用瑞克斯芬剩下常規藥物醫生這些人均她們

A relatively higher incidence of polyps occurred in the raloxifene group (4. 7%).

雷洛治療息肉發生率相對較高(4.7%)。

Effects of raloxifene on the ERE transcription activity and its relationship with estrogen receptor subtypes in vascular endothelial cells

雷洛血管內皮細胞ERE轉錄活性影響雌激素受體亞型關系

Preparation of raloxifene hydrochloride capsules and establishment of its quality control standard

鹽酸雷洛膠囊制備及其質量標準研究

A double blind, randomized, placebo-controlled study for raloxifene hydrochloride in prevention and treatment of menopausal osteoporosis

鹽酸雷洛防治絕經骨質疏松癥隨機對照研究

Synthesis of raloxifene hydrochloride as selective estrogen receptor modulator

選擇性雌激素受體調節鹽酸雷洛合成

Effects of raloxifene on the proliferation and differentiation of bone marrow stromal cells from the osteoporosis rats

雷諾骨質疏松骨髓基質細胞影響

Incidence Of Urinary Incontinence In Postmenopausal Women Treated With Raloxifene Or Estrogen

雷洛雌激素治療絕經后婦女尿失禁影響

Influence of SERM-raloxifene on bone mineral density and blood biochemical parameters in ovariectomized rats

雷諾去勢后密度生化指標影響

Prevention of bone loss by selective estrogen receptor modulators: raloxifene in the ovariectomized rat

選擇性激素受體調節劑雷洛阻止去卵巢大鼠丟失機制

Determination of related substances in raloxifene hydrochloride raw medicine by HPLC

高效色譜測定鹽酸雷洛原料有關物質

Alendronate May Offer Better Improvements in Bone Mineral Density and Bone Turnover Than Raloxifene

阿侖改善密度轉換標記效果優于雷洛

Improved synthesis of raloxifene hydrochloride

鹽酸雷洛合成改進

Effects of Raloxifene on Prevention and Treatment of Bone Loss in Ovariectomized Rats

雷洛去卵巢大鼠丟失防治作用

Effect of raloxifene on human tissues except bone tissue

雷洛組織影響

Raloxifene May Lower Stroke Risk in Some Postmenopausal Women

雷洛可能降低某些絕經后女性危險

The Use of Raloxifene in Osteoporosis Treatment

雷諾骨質疏松癥治療應用